Landmark procedure strengthens Africa's capacity for complex cardiac care, reducing reliance on overseas medical travel ...

Severe air pollution forced the Delhi government on Monday to suspend physical classes for younger students, directing ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

BeyondSpring (BYSI) announced results from the Asian subset of its global Phase 3 DUBLIN-3 trial evaluating Plinabulin plus docetaxel compared to ...

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...

Preclinical data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Ka, strongly inhibits pAKT signaling in tumor cells without inducing hyperglycemia, and shows robust anti-tumor activity ...

Merck’s Keytruda, the category-defining CPI, reported $29.5 billion in revenue in 2024, with NSCLC representing an estimated 30% of its total sales. Keytruda is expected to approach $35 billion by ...

A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care ...

Nuvalent Inc. (NASDAQ:NUVL) is one of the best 52-week high stocks to buy right now. On November 24, Truist Securities ...

Abstract: Lung cancer is the most common cause of cancer-related mortality globally. Early diagnosis of this highly fatal and prevalent disease can significantly improve survival rates and prevent its ...